Trial Summary
What is the purpose of this trial?
This trial tests a home-based therapy program called HOME for people with long-term TBI symptoms and their families. Therapists visit homes to help adjust the living environment and teach coping strategies. The goal is to improve patients' quality of life and reduce caregiver stress.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the HOME Program for Traumatic Brain Injury treatment?
Some studies suggest that home-based occupational therapy can improve outcomes for stroke patients, and high utilization of occupational therapy in acute care settings for traumatic brain injury is associated with changes in daily living activities, although it may not always lead to community discharge. Further research is needed to confirm these findings.12345
Is the HOME Program for Traumatic Brain Injury safe for humans?
The HOME Program for Traumatic Brain Injury includes medical treatment, evaluations, and counseling, and has been studied in a controlled trial without showing any safety concerns. Participants received guidance on home activities and support through weekly calls, indicating a focus on safe and supportive care.16789
How is the HOME Program treatment for traumatic brain injury different from other treatments?
Research Team
Laraine Winter, PhD
Principal Investigator
Villanova University, M. Louise Fitzpatrick College of Nursing and Corporal Michael J. Crescenz VA Medical Ctr.
Helene Moriarty, PhD, RN, FAAN
Principal Investigator
Villanova University, M. Louise Fitzpatrick College of Nursing and Corporal Michael J. Crescenz VA Medical Ctr.
Eligibility Criteria
This trial is for individuals with chronic symptoms from a traumatic brain injury (TBI) that occurred over a year ago, and their family members who live with them and are actively involved in their lives. Participants must be adults who speak English and can consent to the study. It's not for those with dementia, recent violence or psychosis, or difficulty understanding interview questions.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the HOME intervention, consisting of 6 in-home sessions and 2 phone sessions over four months, focusing on managing TBI-related symptoms through environmental modifications and family education.
Follow-up
Participants are monitored for maintenance of treatment effects and generalization of skills to new problems or contexts.
Long-term Follow-up
Assessment of long-term maintenance of treatment effects and generalization of skills 10 months after baseline.
Treatment Details
Interventions
- Attention-control condition (Behavioural Intervention)
- HOME for Us (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Villanova University
Lead Sponsor
Drexel University
Collaborator
Nancy D. Spector
Drexel University
Chief Medical Officer
MD from Drexel University
Denis O'Brien
Drexel University
Chief Executive Officer since 2020
MBA from Drexel University
Thomas Jefferson University
Collaborator
Dr. Eugene Kennedy
Thomas Jefferson University
Chief Medical Officer since 2020
MD
Dr. Joseph G. Cacchione
Thomas Jefferson University
Chief Executive Officer since 2022
MD, MBA
University of Pennsylvania
Collaborator
Dr. Joan Lau
University of Pennsylvania
Chief Executive Officer since 2020
PhD in Neuroscience from the University of Cincinnati College of Medicine, MBA from the Wharton School of Business, BS in Bioengineering from the University of Pennsylvania
Dr. Robert Iannone
University of Pennsylvania
Chief Medical Officer since 2019
MD from Yale University, MSCE from the University of Pennsylvania
Louisiana State University Health Sciences Center - New Orleans
Collaborator